Advanced search
Publication Cover
Drug and Alcohol Review Volume 22, 2003 - Issue 4
Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity

Robert Ali Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia; Drug and Alcohol Services Council, South AustraliaCorrespondence[email protected]
,
Peter Thomas Intensive Care Unit, Royal Adelaide Hospital, South Australia
,
Jason White Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia; Drug and Alcohol Services Council, South Australia
,
Catherine McGregor Drug and Alcohol Services Council, South Australia
,
Catherine Danz Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia
,
Linda Gowing Drug and Alcohol Services Council, South Australia
,
Amanda Stegink Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia
&
Peter Athanasos Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia
 show all
Pages 425-431 | Received 18 Jul 2002, Accepted 31 Jul 2003, Published online: 12 Jul 2009

References

  • Rawson RA, Tennant Jr FS. Five-year follow-up of opiate addicts with naltrexone and behavior therapy. NIDA Res Monogr 1984;49:289–95.
  • Roth A, Hogan I, Farren C. Naltrexone plus group therapy for the treatment of opiate-abusing health-care profes- sionals. J Subst Abuse Treat 1997;14:19–22.
  • Washton AM, Gold MS, Pottash AC. Successful use of naltrexone in addicted physicians and business executives. Adv Alcohol Subst Abuse 1984;4:89–96.
  • Tucker TK, Ritter AJ. Naltrexone in the treatment of heroin dependence: a literature review. Drug Alcohol Rev 2000;19:73–82.
  • Fishbain DA, Rosomoff HL, Cutler R, Rosomoff RS. Opiate detoxification protocols. A clinical manual. Ann Clin Psychiatry 1993;5:53–65.
  • Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996;347:97–100.
  • Farrell M. Opiate withdrawal. Addiction 1994;89:1471–5.
  • Bearn J, Gossop M, Strang J. Rapid opiate detoxification treatments. Drug Alcohol Rev 1999;18:75–81.
  • Gossop M. Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend 1988;21:253–9.
  • Brewer C. Ultra-rapid, antagonist-precipitated opiate de- toxification under general anaesthetic or sedation. Addict Biol 1997;2:291–302.
  • Simon DL. Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art. J Addict Dis 1997;6:103–22.
  • Hall W, Mattick RP. Ultrarapid opiate detoxification. Med J Aust 1997;167:393–6.
  • McGregor C, Ali R, White JM, Thomas P, Gowing L. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug Alcohol Depend 2002;68:5–14.
  • Kreek MJ. Methadone-related opioid agonist pharma- cotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 2000;909:186–216.
  • Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607–14.
  • Handelsman L, Cochrane KJ, Aronson MJ, Ness RA, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13:293–308.
  • McDonald T. Plasma naltrexone during opioid detoxifica- tion. J Addict Dis 2000;19:59–64.
  • Osterwalder JJ. Naloxone—for intoxications with intrave- nous heroin and heroin mixtures—harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996;34:409–16.
  • Gowing LR, Ali RL, White JM. Opioid antagonists under sedation or anaesthesia for opioid withdrawal [Cochrane review]. In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
  • Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone-accelerated detox- ification in opioid dependence. Med J Aust 1999;171:26–30.
  • Allhoff T, Renzing-Kohler K, Kienbaum P, Sack S, Scherbaum N. Electrocardiographic abnormalities during recovery from ultra-short opiate detoxification. Addict Biol 1999;4:337–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.